Porokeratoses

1. ALEXIS, A. F., BUSAM, K., MYSKOWSKI, P. L. Porokeratosis of Mibelli following bone marrow transplantation. Int. J. Dermatol., 2006, 45, 4, p. 361–365.

2. ALSTER, T. S., NANNI, C. A. Successful treatment of porokeratosis with 585 nm pulsed dye laser irradiation. Cutis, 1999, 63, 5, p. 265–266.

3. ALLEN, A. L., GLASER, D. A. Disseminated superficial actinic porokeratosis associated with topical PUVA. J. Am. Acad. Dermatol., 2000, 43, p. 720–722.

4. ANDERSON, D. E., CHERNOSKY, M. E. Disseminated superficial actinic porokeratosis. Genetic aspects. Arch. Dermatol., 1969, 99, p. 408–412.

5. ANDREW, G. C. Porokeratosis (Mibelli) disseminated and superficial type. Arch. Dermatol. Syphilol., 1937, 36, p. 1111–1114.

6. ASUMALAHTI, K., LAITINEN, T., LAHERMO, P. et al. Psoriasis susceptibility locus on 18p revealed by genome scan in Finnish families not associated with PSORS1. J. Invest. Dermatol., 2003, 121, p. 735–740.

7. BATALLA, A., ROSÓN, E., DE LA TORRE, C. Porokeratoma: a different entity or a variant of verrucous (hyperkeratotic) porokeratosis? Indian. J. Dermatol., 2013, 58, 2, p. 158.

8. BEDNAREK, R., EZRA, N., TOUBIN, Y. et al. Eruptive disseminated porokeratosis associated with corticosteroid-induced immunosuppression. Clin. Exp. Dermatol., 2015, 40, 7, p. 753–756.

9. BENCINI, P. L., CROSTI, C., SALA, F. Porokeratosis: immunosuppression and exposure to sunlight. Br. J. Dermatol., 1987, 116, 1, p. 113–116.

10. BHASKAR, S., JAISWAL, A. K., RAJ, N. Porokeratosis – Head to toe: An unusual presentation. Indian Dermatol. Online J., 2015, 6, 2, p. 101–104.

11. BRAUER, J. A., MANDAL, R., WALTERS, R. et al. Disseminated superficial porokeratosis. Dermatol. Online J., 2010, 15, 16, p. 20.

12. BROWN, P. C. Punctate keratoderma. Arch. Dermatol., 1971, 104, p. 682–683.

13. CAO, H. M., WANG, Z. Y., ZHANG, G. W. et al. Identification of a locus (DSP2) for disseminated superficial porokeratosis at chromosome 12q21.2–24.21. Clin. Exp. Dermatol., 2012, 37, p. 672–676.

14. CAVICCHINI, S., TOURLAKI, A. Successful treatment of disseminated superficial actinic porokeratosis with methyl aminolevulinatephotodynamic therapy. J. Dermatol. Treat., 2006, 17, p. 190–191.

15. COCKERELL, C. J. Induction of disseminated superficial actinic porokeratosis by phototherapy for psoriasis. J. Am. Acad. Dermatol., 1991, 24, p. 301–302.

16. CURKOVA, A. K., HEGYI, J., KOZUB, P. et al. A case of linear porokeratosis treated with photodynamic therapy with confocal microscopy surveillance. Dermatol. Ther., 2014, 27, 3, p. 144–147.

17. DANBY, W. Treatment of porokeratosis with fluorouracil and salicylic acid under occlusion. Dermatol. Online J., 2003, 9, p. 33.

18. DELFINO, M., ARGENZIANO, G., NINO, M. Dermoscopy for the diagnosis of porokeratosis. J. Eur. Acad. Dermatol. Venereol., 2004, 18, 2, p. 194–195.

19. DERVIS, E., DEMIRKESEN, C. Generalized linear porokeratosis. Int. J. Dermatol., 2006, 45, 9, p. 1077–1079.

20. DE SIMONE, C., PARADISI, A., MASSI, G. et al. Giant verrucous porokeratosis of Mibelli mimicking psoriasis in a patient with psoriasis J. Am. Acad. Dermatol., 2007, 57, 4, p. 665–668.

21. DIPPEL, E., HAAS, N., CZARNETZKI, B. M. Porokeratosis of Mibelli associated with active chronic hepatitis and vitiligo. Acta Derm. Venereol., 1994, 74, 6, p. 463–464.

22. FERNÁNDEZ-GUARINO, M., HARTO, A., PÉREZ-GARCIA, B. et al. Photodynamic therapy in disseminated superficial actinic porokeratosis. J. Eur. Acad. Dermatol. Venereol., 2009, 23, p. 176–177.

23. FLANAGAN, N., BOYADJIEV, S. A., HARPER, J. et al. Familial craniosynostosis, anal anomalies, and porokeratosis: CAP syndrome. J. Med. Genet., 1998, 35, 9, p. 763–736.

24. GARCIA-NAVARRO, X., GARCÉS, J. R., BASELGA, E. et al. Linear porokeratosis. Excellent response to photodynamic therapy. Arch Dermatol., 2009, 145, p. 526–527.

25. GIULIODORI, K., CAMPAATI, A., GANZETTI, G. et al. The successful offlabel use of photodynamic therapy for classic porokeratosis of Mibelli: case report. Dermatol. Ther., 2011, 24, p. 501–504.

26. GODDARD, D. S., ROGERS, M., FRIEDEN, I. J. et al. Widespread porokeratotic adnexal ostial nevus: clinical features and proposal of a new name unifying porokeratotic eccrine ostial and dermal duct nevus and porokeratotic eccrine and hair follicle nevus. J. Am. Acad. Dermatol., 2009, 61, p. 1060.

27. GOULDING, J., TEOH, J., CARR, R. et al. Eruptive disseminated superficial porokeratosis with rapid resolution: a drug induced phenomenon? Clin. Exp. Dermatol., 2009, 34, p. 895–897.

28. GU, C. Y., ZHANG, C. F., CHEN, L. J. et al. Clinical analysis and etiology of porokeratosis. Exp. Ther. Med., 2014, 8, 3, p. 737–741.

29. GUARNERI, C., CANNAVO, S., LENTINI, M. et al. Adalimumab induced disseminated superficial porokeratosis. Ann. Pharmacother., 2011, 45, 2, p. 280–281.

30. GUO, H., GAO, X. H., CHEN, H. D. Coexistence of multiple variants of porokeratosis. Indian J. Dermatol. Venereol. Leprol., 2015, 81, 4, p. 402–403.

31. GUSS, S. B., OSBOURN, R. A., LUTZNER, M. A. Porokeratosis plantaris, palmaris, et disseminata. A third type of porokeratosis. Arch Dermatol., 1971, 104, p. 366–373.

32. GUTIÉRREZ PAREDES, E., BELLA NAVARRO, R., MONTESINOS VILLAESCUSA. E. et al. Porokeratosis of Mibelli: A new indication for photodynamic therapy? Actas Dermosifilogr., 2013, 104, p. 259–261.

33. HAPPLE, R. Dohi Memorial Lecture. New aspects of cutaneous mosaicism. J. Dermatol., 2002, 29, 11, p. 681–692.

34. HAPPLE, R. Mibelli revisited: a case of type 2 segmental porokeratosis from 1893. J. Am. Acad. Dermatol., 2010, 62, 1, p. 136–138.

35. HILL, M. P., BALME, B., GHO, A., PERROT, H. Superficial disseminated porokeratosis with dermal amyloidosis. Ann. Dermatol. Venereol., 1992, 119, p. 651–654.

36. HIVNOR, C., WILLIAMS, N., SINGH, F. et al. Gene expression profiling of porokeratosis demonstrates similarities with psoriasis. J. Cutan. Pathol., 2004, 31, p. 657–664.

37. CHEN, T. J., CHOU Y. C., CHEN C. H. et al. Genital porokeratosis: a series of 10 patients and review of the literature. Br. J. Dermatol., 2006, 155, 2, p. 325–329.

38. CHERNOSKY, M. E., FREEMAN, R. G. Disseminated superficial actinic porokeratosis (DSAP). Arch. Dermatol., 1967, 96, p. 611–624.

39. IRISAWA, R., YAMAZAKI, M., YAMAMOTO, T. et al. A case of porokeratosis plantaris palmaris et disseminata and literature review. Dermatol. Online J., 2012, 18, p. 5.

40. JAMES, A. J., CLARKE, L. E., ELENITSAS, R. et al. Segmental porokeratosis after radiation therapy for follicular lymphoma. J. Am. Acad. Dermatol., 2008, 58, 2, p. 49–50.

41. KAFKOVÁ, H., ŠTORK, J., VOSMÍK, F. et al. Porokeratosis gigantea. Čes.-slov. Derm., 2005, 80, 1, p. 23–25.

42. KANITAKIS, J. Porokeratoses: an update of clinical, aetiopathogenic and therapeutic features. Eur. J. Dermatol., 2014, 24, p. 533–544.

43. KANITAKIS, J., ARBONA-VIDAL, E., FAURE, M. Porokeratosis in patients with polycythemia rubra vera: a new side-effect of hydroxyurea? J. Eur. Acad. Dermatol. Venereol., 2012, 26, p. 1040–1041.

44. KANITAKIS, J., MISERY, L., NICOLAS, J. F. et al. Disseminated superficial porokeratosis in a patient with AIDS. Br. J. Dermatol., 1994, 131, 2, p. 284–289.

45. KANITAKIS, J., RIVAL-TRINGALI, A. L., CHOUVET, B. et al. J. Cutan. Pathol., 2009, 36, 7, p. 804–807.

46. KIM, M. S., HA, J. M., CHO, E. B. et al. Porokeratosis presenting with a benign lichenoid keratosis-like appearance. Ann. Dermatol., 2015, 27, 6, p. 778–779.

47. KIM, D. S., ROH, M. R., LEE, J. H. et al. Pterygium unguis formation in porokeratosis of Mibelli. Br. J. Dermatol., 2007, 156, p. 1384–1385.

48. KINDEM, S., SERRA-GUILLÉN, C., SORNI, G. et al. Treatment of porokeratosis of Mibelli with ingenol mebutate: a possible new therapeutic option. JAMA Dermatol., 2015, 151, 1, p. 85–86.

49. KROISS, M., STOLZ, W., HOHENLEUTNER, U. et al. Disseminated superficial porokeratosis induced by furosemide. Acta Derm. Venereol., 2000, 80, p. 52–53.

50. LEDERMAN, J. S., SOBER, A. J., LEDERMAN, G. S. Immunosuppression: a cause of porokeratosis? J. Am. Acad. Dermatol., 1985, 13, 1, p. 75–79.

51. LEVITT, J., EMER, J. J., EMANUEL, P. O. Treatment of porokeratosis of Mibelli with combined use of photodynamic therapy and fluorouracil cream. Arch. Dermatol., 2010, 146, p. 371–373.

52. LIU, H. T. Treatment of lichen amyloidosis (LA) and disseminated superficial porokeratosis (DSP) with frequency-doubled Q-switched Nd: YAG laser. Dermatol. Surg., 2000, 26, 10, p. 958–962.

53. LIU, P., ZHANG, S., YAO, Q. et al. Identification of a genetic locus for autosomal dominant disseminated superficial actinic porokeratosis on chromosome 1p31.3- p31.1. Hum. Genet., 2008, 123, p. 507–513.

54. LOLIS, M. S., MARMUR, E. S. Treatment of disseminated superficial actinic porokeratosis (DSAP) with the Q-switched ruby laser. J. Cosmet. Laser Ther., 2008, 10, 2, p. 124–127.

55. LUAN, J., NIU, Z., ZHANG, J. et al. A novel locus for disseminated superficial actinic porokeratosis maps to chromosome 16q24.1-24.3. Hum. Genet., 2011, 129, p. 329–334.

56. LUCKER, G. P., HAPPLE, R., STEIJLEN, P. M. An unusual case of porokeratosis involving the natal cleft: porokeratosis ptychotropica? Br. J. Dermatol., 1995, 132, 1, p. 150–151.

57. MA, Y., LI, C., WU, J. Coexistence of porokeratosis ptychotropica with porokeratosis of Mibelli in a Chinese man. Postepy Dermatol. Alergol., 2015, 32, 4, p. 307–309.

58. MARKS, S., VARMA, R., CANTRELL, W. et al. Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis. J. Eur. Acad. Dermatol. Venereol., 2009, 23, 1, p. 42–45.

59. MACMILLAN, A. L., ROBERTS, S. O. Porokeratosis of Mibelli after renal transplantation. Br. J. Dermatol., 1974, 90, 1, p. 45–51.

60. MCDONALD, S. G., PETERKA, E. S. Porokeratosis (Mibelli): treatment with topical 5 -fluorouracil. J. Am. Acad. Dermatol., 1983, 8, p. 107–110.

61. MCGUIGAN, K., SHURMAN, D., CAMPANRLLI, C. et al. Porokeratosis ptychotropica: A clinically distinct variant of porokeratosis. J. Am. Acad. Dermatol., 2008, 60, 3, p. 501–503.

62. MEHREGAN, A., KHALILI, H., FAZEL, Z. Mibelli’s porokeratosis of the face. A report of seven cases. J. Am. Acad. Dermatol., 1980, 3, p. 394–396.

63. MIBELLI, V. Contribute allo studio della ipercheratosi dei canali sudoriferi (porocheratosis). G. Ital. Mal. Ven., 1893, 28, p. 313–355.

64. MIZUKAWA, Y., SHIOHARA, T. Porokeratosis in patients with hepatitis C virus infection: does hepatitis C virus infection provide a link between porokeratosis and immunosuppression? Br. J. Dermatol., 1999, 141, 1, p. 163–164.

65. MIZUKAWA, Y., SHIOHARA, T. Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: With emphasis on EB virus, human herpesvirus 6 and hepatitis C virus. J. Dermatol. Sci., 2000, 22, 3, p. 169–180.

66. MOSCARELLA, E., LONGO, C., ZALAUDEK, I. et al. Dermoscopy and confocal microscopy clues in the diagnosis of psoriasis and porokeratosis. J. Am. Acad. Dermatol., 2013, 69, p. 231–233.

67. MUNDI, J. P., CERULLO, L., COTLIAR, J. Porokeratosis in a patient with hepatitis of unclear etiology. J. Drugs Dermatol., 2010, 9, 3, p. 258–260.

68. MURASE, J., GILLIAM, A. Disseminated superficial actinic porokeratosis co-existing with linear and verrucous porokeratosis in an elderly woman: update on the genetics and clinical expression of porokeratosis. J. Am. Acad. Dermatol., 2010, 63, p. 886–891.

69. NAHM, W. K., DONOHUE, K. G., DANAHY, J. F. et al. Systemic 5 -fluorouracil producing an inflammatory response in porokeratosis. J. Eur. Acad. Dermatol. Venereol., 2003, 17, 2, p. 190–192.

70. NAINENI, K. K., HOHLE, R., LUCKE, T. Disseminated superficial actinic porokeratosis of the scalp. Clin. Exp. Dermatol., 2007, 32, 2, p. 222–223.

71. NAKAMURA, M., FUKAMACHI, S., TOKURA, Y. Acute onset disseminated superficial porokeratosis associated with exacerbation of diabetes mellitus due to development of anti-insulin antibodies. Dermatoendocrinol., 2010, 2, 1, p. 17–18.

72. NAKAMURA, Y., YAMAGUCHI, M., NAKAMURA, A. et al. Calcipotriol and adapalene therapy for disseminated superficial actinic porokeratosis. Indian J. Dermatol. Venereol. Leprol., 2014, 80, 4, p. 373–374.

73. NAYEEMUDDIN, F. A., WONG, M., YELL, J. et al. Topical photodynamic therapy in disseminated superficial actinic porokeratosis. Clin. Exp. Dermatol., 2002, 27, p. 703–706.

74. NEUMANN, R. A., KNOBLER, R. M., GEBHART, W. Unusual presentation of porokeratosis palmaris, plantaris et disseminata. J. Am. Acad. Dermatol., 1989, 21, 5, p. 1131–1133.

75. NEUMANN, R. A., KNOBLER, R. M., JURECKA, W. et al. Disseminated superficial actinic porokeratosis: experimental induction and exacerbation of skin lesions. J. Am. Acad. Dermatol., 1989, 21, p. 1182–1188.

76. NEUMANN, R., KNOBLER, R., METZE, D., JURECKA, W., GEBHART, W. Disseminated superficial actinic porokeratosis: experimental induction and exacerbation of skin lesions. J. Am. Acad. Dermatol., 1989, 21, p. 1182–1188.

77. OCCELLA, C., BLEIDL, D., NOZZA, P. Identification of an interstitial 18p11.32-p11.31 duplication including the EMILIN2 gene in a family with porokeratosis of Mibelli. PLoS One, 2013, 10, 8, 4, e61311.

78. PAREKH, V., KABIHTING, F. D., JUNKINS-HOPKINS, J. M. Hyperkeratotic variant of porokeratosis in a patient with Hepatitis C virus infection and a concomitant immunosuppressed state. Dermatol. Online J., 2015, 18, 21, p. 11.

79. RAHMAN, M., ANSARI, N., HADIUZZAMAN, M. A giant porokeratosis of Mibelli: successful treatment with topical 5 percent fluorouracil. Egypt Dermatol. Online J., 2011, 7, p. 7.

80. REED, R. J., LEONE, P. Porokeratosis-a mutant clonal keratosis of the epidermis. I. Histogenesis. Arch Dermatol., 1970, 101, p. 340–347.

81. RICCI, C., ROSSET, A., PANIZZON, R. Bullous and pruritic variant of disseminated superficial actinic porokeratosis: successful treatment with grenz rays. Dermatology, 1999, 199, p. 328–331.

82. RODRÍGUEZ, E. A., JAKUBOWICZ, S., CHINCHILLA, D. A. et al. Porokeratosis of Mibelli and HIV-infection. Int. J. Dermatol., 1996, 35, 6, p. 402–404.

83. ROSON, E., GARCIA-DOVAL, I., DE LA TORRE, C. et al. Disseminated superficial porokeratosis with mucosal involvement. Acta Derm. Venereol., 2001, 81, p. 64–65.

84. ROSS, N. A., ROSENBAUM, L. E., SAEDI, N. et al. Disseminated superficial actinic porokeratosis improved with fractional 1927-nm laser treatments. J. Cosmet. Laser Ther., 2016, 28, p. 1–3.

85. SAKAS, E. L., GENTRY, R. H. Porokeratosis punctata palmaris et plantaris (punctate porokeratosis): case report and literature review. J. Am. Acad. Dermatol., 1985, 13, p. 908–912.

86. SASSON, M., KRAIN, A. D. Porokeratosis and cutaneous malignancy. A review. Dermatol. Surg., 1996, 22, 4, p. 339–342.

87. SERTZNIG, P., VON FELBERT, V., MEGAHED, M. Porokeratosis: present concepts. J. Eur. Acad. Dermatol. Venereol., 2012, 26, p. 404–412.

88. SEHGAL, V. N., DUBE, B. Porokeratosis (Mibelli) in a family. Dermatologica, 1967, 134, p. 219–224.

89. SHELLEY, W. B., SHELLEY, E. D. Disseminated superficial porokeratosis: rapid therapeutic response to 5- fluorouracil. Cutis, 1983, 32, p. 139–140.

90. SHEN, C. S., TABATA, K., MATSUKI, M. et al. Premature apoptosis of keratinocytes and the dysregulation of keratinization in porokeratosis. Br. J. Dermatol., 2002, 147, p. 498–502.

91. SHOIMER, I., ROBERTSON L., H., STORWICK, G., HABER. M., R. Eruptive disseminated porokeratosis: A new classification system. J. A. Acad. Dermatol., 2014, 71, 2, p. 398–400.

92. SILVER, S., CRAWFORD, R. Fatal squamous cell carcinoma arisingfrom transplant-associated porokeratosis. J. Am. Acad. Dermatol., 2003, 49, p. 931–933.

93. STEVENS, H. P., KELSELL, D. P., BRYANT, S. P. et al. Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24: literature survey and proposed updated classification of the keratodermas. Arch. Derm., 1996, 132, p. 640–651.

94. STEWART, L., HOWAT, A., COULSON, I. Disseminated superficial porokeratosis secondary to immunosuppression induced by etanercept for extensive psoriasis. Arch Dermatol., 2010, 46, p. 1193–1194.

95. STORK, J., KODETOVA, D. Disseminated superficial porokeratosis: an eruptive pruritic papular variant. Dermatology, 1997, 195, 3, p. 304–305.

96. TEIXEIRA, S., NASCIMENTO, M., BAGATIN, E. et al. The use of fluor-hydroxy pulse peel in actinic porokeratosis. Dermatol. Surg., 2005, 31, p. 1145–1148.

97. TERRANOVA, M., AMATO, L., MASSI, D. et al. Disseminated superficial actinic porokeratosis in a patient with Sjögren syndrome. Skinmed., 2003, 2, 6, p. 390–391.

98. TRCKA, J., PETTKE-RANK, C. V., BROCKER, E. B. et al. Genitoanocrural porokeratosis following chronic exposure to benzene. Clin. Exp. Dermatol., 1998, 23, p. 28–31.

99. UHARA, H., KAMIJO, F., OKUYAMA, R. et al. Open pores with plugs in porokeratosis clearly visualized with the dermoscopic furrow ink test: report of 3 cases. Arch. Dermatol., 2011, 147, 7, p. 866–868.

100. ULRICH, M., FORSCHNER, T., RÖWERT-HÜBER, J., et al. Differentiation between actinic keratoses and disseminated superficial actinic porokeratoses with reflectance confocal micrscopy. Br. J. Dermatol., 2007, 156, 3, p. 47–52.

101. VON FELBERT, V., NEIS, M., MEGAHED, M. et al. Imaging of actinic porokeratosis by optical coherence tomography. Hautarzt, 2008, 59, p. 877–879.

102. VASUDEVAN, B., CHATTERJEE, M., GREWAL, R. A case of disseminated superficial porokeratosis associated with giant porokeratosis in pregnancy. Indian J. Dermatol., 2014, 59, 5, p. 492–494.

103.VENECIE, P. Y., VEROLA, O., PUISSANT, A. Porokeratosis in primary biliary cirrhosis during plasmapheresis. J. Am. Acad. Dermatol., 1986, 15, 4, p. 709–710.

104. VOSMÍK, F. Porokeratosis. In Štork, J. et al. Dermatovenerologie. Praha: Galén, 2008, p. 360–362.

105. WALSH, S. N., HURT, M. A., SANTA CRUZ, D. J. Porokeratoma (porokeratotic acanthoma): immunohistological study of a new case. Am. J. Surg. Pathol., 2007, 31, 12, p. 1897–1901.

106. WEI, S., YANG, S., LIN, D. et al. A novel locus for disseminated superficial porokeratosis maps to chromosome 18p11.3. J. Invest. Dermatol., 2004, 123, p. 872–875.

107. WEI, S. C., YANG, S., LI, M. et al. Identification of a locus for porokeratosis palmaris et plantaris disseminata to a 6.9- cM region at chromosome 12q24.1- -24.2. Br. J. Dermatol., 2003,149, 2, p. 261–267.

108. WEI, S., ZHANG, T. D., ZHOU, Y. et al. Fine mapping of the disseminated superficial porokeratosis locus to a 2.7 Mb region at 18p11.3. Clin. Exp. Dermatol., 2010, 35, p. 664–667.

109. XIA, J. H., YANG, Y. F., DENG, H. et al. Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1. J. Invest. Dermatol., 2000,114, p. 1071–1074.

110. XIA, K., DENG, H., XIA, J. H. et al. A novel locus (DSAP2) for disseminated superficial actinic porokeratosis maps to chromosome 15q25.1-26.1. Br. J. Dermatol., 2002, 147, p. 650–654.

111. YAZAKAN, F., TURK, B. G., DERELI, T. et al. Porokeratosis of Mibelli induced by topical corticosteroid. J. Cutan. Pathol., 2006, 33, p. 516–518.

112. ZABALLOS, P., PUIG, S., MALVEHY, J. Dermoscopy of disseminated superficial actinic porokeratosis. Arch. Dermatol., 2004, 40, 11, p. 1410.

113. ZHANG, S. Q., JIANG, T., LI, M. et al. Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis. Nat. Genet., 2012, 44, p. 1156–1160.

114. ZHANG, Z. H., WANG, Z. M., CROSBY, M. E. et al. Gene expression profiling of porokeratosis. J. Cutan. Pathol., 2008, 35, p. 1058–1062.

115. ZHAO, M., SANUSI, T., ZHAO, Y. et al. Porokeratosis with follicular involvement: report of three cases and review of literatures. Int. J. Clin. Exp. Pathol., 2015, 1, 8, 4, p. 4248–4252.